Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061113 · ClinicalTrials.gov registry record · Phase 4
Substance Dependent Teens - Impact of Treating Depression Study 1 - 1
A Phase 4 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 4
- Development phase
- 126
- Enrollment target
NCT00061113 is a Phase 4 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 126 participants.
The verdict
NCT00061113, a Phase 4 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 126 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of treating depression on substance dependent teens.
Interventions
- DRUG fluoxetine
- DRUG Fluoxetine + outpatient cognitive behavioral therapy
- DRUG placebo + CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2001-02 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00061113
The ClinicalTrials.gov registry entry for NCT00061113 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which fluoxetine is the first listed.
NCT00061113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00061113 about?
NCT00061113 is a clinical study titled "Substance Dependent Teens - Impact of Treating Depression Study 1 - 1". The purpose of this study is to evaluate the impact of treating depression on substance dependent teens.
What is the current status of trial NCT00061113?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 126 participants. The study started on 2001-02. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00061113?
The interventions under investigation include: fluoxetine (DRUG), Fluoxetine + outpatient cognitive behavioral therapy (DRUG), placebo + CBT (DRUG).
Who is sponsoring clinical trial NCT00061113?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.